Longitude raises $525m for third fund

Menlo Park-based venture capital firm Longitude Capital has closed on a new biotech and life sciences fund.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.